Sisi Chan

Investors quietly pile into a group of stocks for 2026 (it’s not healthcare)

Introduction: In an insightful analysis presented by Todd Cambell, edited by Daniel Kline, a sector has been identified that is quietly outperforming technology.

Key Points: Healthcare stocks are silently outperforming technology; S&P 500 is currently dominated by technology; various drivers fuel healthcare momentum.

Personal Background and Methodology: Todd Campbell’s professional journey has led to the development of a unique stocks and sector ranking tool that helps identify emerging market trends.

Limelight Alpha Sector Ranking: Healthcare stocks have exhibited an uptrend since June, when they first appeared at the top of the large-cap sector ranking.

Comparison: Technology vs Healthcare: Despite the dominance of technology stocks, like Nvidia, there is a recognizable shift towards healthcare stocks.

Current Market Condition and Projection for 2026: Investors show a considerable interest in technology stocks. However, Cambell suggests that the market trend may lean towards healthcare stocks as potential investments for the upcoming years.

Diversification and Projection for 2026: Over-investment in technology stocks, involving companies such as Meta, Alphabet, and Amazon, could potentially lead to negative consequences.

Rotation toward Healthcare: An anticipated slowdown in technology stocks could stimulate investors to consider other sectors, notably healthcare.

Ranking Data and Shift towards Healthcare: Cambell’s ranking model examines several criteria, identifying a gradual shift towards healthcare stocks amidst regulatory scrutiny.

Consideration for Investing in Healthcare Stocks: Investors need to consider factors like regulatory risks, merger and acquisition opportunities, and falling interest rates when looking towards healthcare stocks.

Momentum in Healthcare and Individual Companies: Certain healthcare companies, including Eli Lilly, Amgen, Johnson & Johnson, and Merck, show promising performances.

Biotech Sector Performance: There is a rise in the performance of the biotech sector and its ETFs, notably the iShares Biotech ETF and the SPDR S&P 500 Biotech ETF when compared with respective technology and healthcare ETFs.

Healthcare Stocks: To Buy or Not to Buy: Cambell examines the most favorable conditions for healthcare sector performances, including reflections on the current state of healthcare stocks and the relative strength index for the XLV and XBI ETF.